CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,620 Cr | ₹5,506 Cr | ₹4,771 Cr | ₹4,057 Cr | ₹3,424 Cr |
What is the latest Sundry Debtors ratio of CIPLA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹5,620 Cr |
| Mar2025 | ₹5,506 Cr |
| Mar2024 | ₹4,771 Cr |
| Mar2023 | ₹4,057 Cr |
| Mar2022 | ₹3,424 Cr |
How is Sundry Debtors of CIPLA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,620 Cr | 2.06 | |
| Mar2025 | ₹5,506 Cr | 15.42 | |
| Mar2024 | ₹4,771 Cr | 17.59 | |
| Mar2023 | ₹4,057 Cr | 18.47 | |
| Mar2022 | ₹3,424 Cr | - | |
Compare Sundry Debtors of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹110,278.4 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
| MANKIND PHARMA | ₹94,050.4 Cr | -1.9% | -5.8% | -12.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.2% |
-6.6% |
-10.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses